As expected, a statistically significant negative association between CA9 expression, and tumor volume was observed for vehicle- and sorafenib-treated xenografts, while VEGF-treated xenografts displayed no relationship (Supplementary Figure S1). This evidence concerns the gene CA9 and neoplasm.